title: Finding a liability-free space in which personalized medicine can bloom.
abstract: Personalized medicine uses genetic and other screening tests to predict a patient's response to specific drug and biologic therapies (together "drugs"), with the aim of choosing a treatment that will provide benefits while avoiding drug-related harms. There are two schools of thought on how tort liability may affect personalized medicine, i.e., whether fear of lawsuits will tend to accelerate progress or slow it down. Tort suits include product liability suits against manufacturers and negligence suits against physicians and other providers of health-related services.
authors: Health Law & Policy Institute and Center on Biotechnology & Law, University of Houston Law Center, Houston, Texas, USA. bjevans@central.uh.edu
authors: B J
authors: BJ
authors: Evans
mesh_terms: D015415:Biomarkers / Q000032:analysis; D016265:Conflict of Interest; D004358:Drug Therapy / Q000941:ethics*; D064420:Drug-Related Side Effects and Adverse Reactions; D026690:Ethics, Clinical; D030661:Genetic Privacy / Q000941:ethics / Q000331:legislation & jurisprudence; D005820:Genetic Testing / Q000941:ethics / Q000331:legislation & jurisprudence; D033161:Government Regulation; D006801:Humans; D007349:Insurance, Health, Reimbursement / Q000941:ethics / Q000331:legislation & jurisprudence; D007880:Legislation, Drug; D016365:Liability, Legal; D018579:Patient Selection / Q000941:ethics*; D010597:Pharmacogenetics / Q000941:ethics* / Q000331:legislation & jurisprudence; D014481:United States
chemical_list: D015415:Biomarkers